CMCL Q1 2026 Earnings Slight EPS Miss Amid Unreported Revenue Stock Declines SHAK Earnings Overview 20260527 PLSE Q1 2026 Earnings EPS Beat but No Revenue as Stock Declines CFFI Q1 2026 Earnings Solid EPS Performance Amid Modest Stock Decline Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline SHAZ Q1 2026 Earnings Significant EPS Miss Sends Stock Higher Despite WiderThanExpected Losses